USA Food and Drug Administration Qualifies the FACE-Q Aesthetics Module as a MDDT
On April 26, 2022, the U.S. Food and Drug Administration (FDA) announced the qualification of the FACE-Q Aesthetics Module for facial aesthetics studies through the agency’s Medical Device Development Tool (MDDT) Program. Qualification of the FACE-Q Aesthetics module included the following 11 scales:
Qualified Self-Perceived Facial Appearance Scales:
1. Satisfaction with Cheeks
2. Satisfaction with Facial Appearance
3. Lines Between Eyebrows
4. Appraisal of Lines: Nasolabial Folds
5. Satisfaction with Lips
6. Satisfaction with Skin
Qualified Health-Related Quality of Life Scales:
1. Aging Appraisal
2. Early Life Impact of Treatment
3. Satisfaction with Outcome
4. Psychological Function
5. Social Function
More information can be found here: https://www.fda.gov/medical-devices/science-and-research-medical-devices/medical-device-development-tools-mddt